The confidentiality of patient and physician information in pharmacy prescription records.
作者信息
Zoutman Dick E, Ford B Douglas, Bassili Assil R
机构信息
Department of Pathology and Molecular Medicine, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.
出版信息
CMAJ. 2004 Mar 2;170(5):815-6. doi: 10.1503/cmaj.1021826.
Abstract
摘要
相似文献
1
The confidentiality of patient and physician information in pharmacy prescription records.药房处方记录中患者和医生信息的保密性。
CMAJ. 2004 Mar 2;170(5):815-6. doi: 10.1503/cmaj.1021826.
2
Privacy of pharmacy prescription records.药房处方记录的隐私性。
CMAJ. 2004 Sep 28;171(7):711-2; author reply 712. doi: 10.1503/cmaj.1040772.
3
Privacy architecture and e-consent. What the future holds.隐私架构与电子同意书。未来会怎样。
J AHIMA. 2007 Jun;78(6):64-5, 70.
4
5
Privacy impact assessments--oversight by the Information and Privacy Commissioner.隐私影响评估——由信息与隐私专员进行监督。
Health Law Can. 2004 Jun;24(4):65-73.
6
Applying legal holds to electronic records.
J AHIMA. 2008 Oct;79(10):72-3, 80.
7
Understanding confidentiality and disclosure of patient information.理解患者信息的保密性与披露
Br J Community Nurs. 2007 Nov;12(11):530-4. doi: 10.12968/bjcn.2007.12.11.27488.
8
HIPAA impacting patient medical information.《健康保险流通与责任法案》影响患者医疗信息。
Tenn Med. 2009 May;102(5):41-2.
9
Overt and covert recordings of health care consultations in Australia: some legal considerations.澳大利亚医疗咨询的公开和秘密录音：一些法律考量
Med J Aust. 2021 Feb;214(3):119-123.e1. doi: 10.5694/mja2.50838. Epub 2020 Nov 1.
10
Medical privacy and research.医疗隐私与研究
J Legal Stud. 2001 Jun;30(2):687-701. doi: 10.1086/342031.
引用本文的文献
1
Commercializing Personal Health Information: A Critical Qualitative Content Analysis of Documents Describing Proprietary Primary Care Databases in Canada.将个人健康信息商业化：对加拿大描述专有的初级保健数据库的文件进行批判性定性内容分析。
Int J Health Policy Manag. 2023;12:6938. doi: 10.34172/ijhpm.2023.6938. Epub 2023 May 2.
2
The best defence is a good offence: Ensuring equitable access to primary care in Canada.最好的防御就是主动出击：确保在加拿大公平获得初级保健。
Healthc Manage Forum. 2023 Sep;36(5):293-298. doi: 10.1177/08404704231182260. Epub 2023 Jul 27.
3
The commercialization of patient data in Canada: ethics, privacy and policy.加拿大患者数据的商业化：伦理、隐私与政策
CMAJ. 2022 Jan 24;194(3):E95-E97. doi: 10.1503/cmaj.210455.
4
Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records.评估从医院处方记录中重新识别患者的风险。
Can J Hosp Pharm. 2009 Jul;62(4):307-19. doi: 10.4212/cjhp.v62i4.812.
5
Evaluating predictors of geographic area population size cut-offs to manage re-identification risk.评估地理区域人口规模临界值的预测因素，以管理重新识别风险。
J Am Med Inform Assoc. 2009 Mar-Apr;16(2):256-66. doi: 10.1197/jamia.M2902. Epub 2008 Dec 11.
6
Evaluating common de-identification heuristics for personal health information.评估个人健康信息的常见去识别启发式方法。
J Med Internet Res. 2006 Nov 21;8(4):e28. doi: 10.2196/jmir.8.4.e28.
7
Privacy of pharmacy prescription records.药房处方记录的隐私性。
CMAJ. 2004 Sep 28;171(7):711-2; author reply 712. doi: 10.1503/cmaj.1040772.
本文引用的文献
1
Paying the PIPEDA.支付《个人信息保护与电子文档法》相关费用
CMAJ. 2003 Jul 8;169(1):5, 7.
2
Patients' consent preferences for research uses of information in electronic medical records: interview and survey data.患者对电子病历中信息用于研究的同意偏好：访谈与调查数据
BMJ. 2003 Feb 15;326(7385):373. doi: 10.1136/bmj.326.7385.373.
3
Principles concerning physician information.关于医生信息的原则。
CMAJ. 2002 Aug 20;167(4):393-6.
4
A call for the regulation of prescription data mining.呼吁对处方数据挖掘进行监管。
CMAJ. 2000 Oct 31;163(9):1146-8.
5
Weaving technology and policy together to maintain confidentiality.将技术与政策相结合以维护保密性。
J Law Med Ethics. 1997 Summer-Fall;25(2-3):98-110, 82. doi: 10.1111/j.1748-720x.1997.tb01885.x.
6
Physicians and the pharmaceutical industry: is a gift ever just a gift?医生与制药行业：礼物仅仅只是礼物吗？
JAMA. 2000 Jan 19;283(3):373-80. doi: 10.1001/jama.283.3.373.
7
Health information privacy code. Canadian Medical Association.健康信息隐私准则。加拿大医学协会。
CMAJ. 1998 Oct 20;159(8):997-1016.
Zotero 插件